Literature DB >> 17483377

B cell depletion in Graves' disease: the right answer to the wrong question?

Terry J Smith.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17483377     DOI: 10.1210/jc.2007-0463

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  5 in total

Review 1.  Targeted biological therapies for Graves' disease and thyroid-associated ophthalmopathy. Focus on B-cell depletion with Rituximab.

Authors:  Laszlo Hegedüs; Terry J Smith; Raymond S Douglas; Claus H Nielsen
Journal:  Clin Endocrinol (Oxf)       Date:  2011-01       Impact factor: 3.478

Review 2.  Selected lid problems in neurologic practice.

Authors:  Gregory S Kosmorsky; Alyssa Fiddler
Journal:  Curr Neurol Neurosci Rep       Date:  2009-09       Impact factor: 5.081

Review 3.  Pathogenesis of Graves' orbitopathy: a 2010 update.

Authors:  T J Smith
Journal:  J Endocrinol Invest       Date:  2010-06       Impact factor: 4.256

4.  Rituximab treatment of patients with severe, corticosteroid-resistant thyroid-associated ophthalmopathy.

Authors:  Dinesh Khanna; Kelvin K L Chong; Nikoo F Afifiyan; Catherine J Hwang; Diana K Lee; Helene Chokron Garneau; Robert A Goldberg; Christine H Darwin; Terry J Smith; Raymond S Douglas
Journal:  Ophthalmology       Date:  2009-10-08       Impact factor: 12.079

5.  Regulation of Lymphocyte Function by PPARgamma: Relevance to Thyroid Eye Disease-Related Inflammation.

Authors:  G M Lehmann; T M Garcia-Bates; T J Smith; S E Feldon; R P Phipps
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.